Expression of RXFP1 in skin of scleroderma patients and control subjects

Scandinavian Journal of Rheumatology

Volumn 41, Issue 5, 2012, Pages 391-395

  Giordano, N ^a   Volpi, N ^a   Franci, D ^a   Corallo, C ^a   Fioravanti, A ^a   Papakostas, P ^a   Montella, A ^a   Biagioli, M ^a   Fimiani, M ^a   Grasso, G ^a   Muscettola, M M ^b   Guerranti, R ^a   Vannoni, D ^a   Galeazzi, M ^a   Nuti, R ^a  

^a Endocrine and Metabolic Sciences and Biochemistry ^*  (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LYSATE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; KERATINOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCLERODERMA; SEBACEOUS GLAND; SKIN BIOPSY; SKIN CELL; SKIN DEFECT; SMOOTH MUSCLE FIBER; SWEAT GLAND; WESTERN BLOTTING;

AGED; CELLS, CULTURED; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; MIDDLE AGED; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84867251291     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2012.669496     Document Type: Article

References (19)

1. Bathgate RA, Samuel CS, Burazin TC, Gundlach AL, Tregear GW. Relaxin: new peptides receptors and novel actions. Trends Endocrinol Metab 2003;14:207-13.
2. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, et al. Activation of orphan receptor by the hormone relaxin. Science 2002;295:671-4.
3. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, et al. Relaxin modulates cardiac fibroblast proliferation differentiation and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 2004;145:4125-33.
4. Unemori EN, Bauer EA,Amento EP. Relaxin alone and in conjunction with interferon-γ decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol 1992;99:337-42.
5. Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, et al. Recombinant human relaxin in the treatment of scleroderma: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000;132:871-9.
6. Khanna D, Clements PJ, Furst DE, Park GS, Hays RD, Yoon J, et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2009;60:1102-11.
7. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54.
9. Cooney TE, Gor RA, Pfaff DW, Schober J. Detection of RXFP1 receptors in skin biopsies from children with congenital adrenal hyperplasia: a preliminary report. J Pediatr Urol 2010;6:389-95.
10. Callander GE, Thomas WG, Bathgate RA. Prolonged RXFP1 and RXFP2 signaling can be explained by poor internalization and a lack of beta-Arrestin recruitment Am J Physiol Cell Physiol 2009;296:C1058-66.
11. Shirota K, Tateishi K, Koji T, Hishikawa Y, Hachisuga T, Kuroki M, et al. Early human preantral follicles have relaxin and relaxin receptor (LGR7), and relaxin promotes their development. J Clin Endocrinol Metab 2005;90:516-21.
12. Lowndes K, Amano A, Yamamoto SY, Bryant-Greenwood GD. The human relaxin receptor (LGR7): expression in the fetal membranes and placenta. Placenta 2006;27:610-18.
13. Dragoo JL, Lee RS, Benhaim P, Finerman GA, Hame SL. Relaxin receptors in the human female anterior cruciate ligament. Am J Sports Med 2003;31:577-84.
14. Novak J, Parry LJ, Matthews JE, Kerchner LJ, Indovina K, Hanley-Yanez K,et al. Evidence for local relaxin ligandreceptor expression and function in arteries. FASEB J 2006;20:2353-62.
15. Morelli SS, Petraglia F, Weiss G, Luisi S, Florio P, Wojtczuk A, et al. Endometrial expression of relaxin and relaxin receptor in endometriosis. Fertil Steril 2010;94:2885-7.
16. Samuel CS, Unemori EN, Mookerjee I, Bathgate RA, Layfield SL, Mak J, et al. Relaxin modulates cardiac fibroblast proliferation differentiation and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 2004;145:4125-33.
17. Muda M, He C, Martini PG, Ferraro T, Layfield S, Taylor D, et al. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Mol Hum Reprod 2005; 11:591-600.
18. Kong RC, Shilling PJ, Lobb DK, Gooley PR, Bathgate RA. Membrane receptors: structure and function of the relaxin family peptide receptors. Mol Cell Endocrinol 2010;320:1-15.
19. Giordano N, Papakostas P, Lucani B, Amendola A, Cipolli F, Agate VM, et al. Serum relaxin in systemic sclerosis. J Rheumatol 2005;32:2164-6.